248
A. A. A. Abdel-Fattah
PAPER
(E)-2-Benzotriazol-1-yl-1-phenyl-3-pyridin-4-yl-propenone
1 H), 3.76 (q, J = 6.9 Hz, 2 H), 3.36 (dd, 2JAB = 7.0 Hz, 3J = 3.0 Hz,
1 H, A part of AB system), 3.32 (dd, 2JAB = 6.8 Hz, 3J = 2.5 Hz, 1
H, B part of AB system), 0.69 (t, J = 6.9 Hz, 3 H).
(5d)
Yield: 0.61 g (62%); mp 138–140 °C.
13C NMR: d = 197.6, 154.1, 144.7, 141.1, 136.8, 135.2, 133.0,
132.3, 129.8, 129.7, 128.9, 128.4, 128.3, 128.0, 127.3, 126.8, 126.6,
123.2, 119.7, 119.1, 110.9, 65.3, 41.4, 41.3, 14.7.
1H NMR: d = 8.10 (d, J = 8.5 Hz, 1 H), 8.05 (d, J = 8.3 Hz, 1 H),
7.92–7.35 (m, 11 H).
13C NMR: d = 192.0, 151.0, 149.2, 145.8, 137.2, 133.8, 131.7,
129.1, 128.9, 127.8, 126.4, 123.6, 119.8, 118.5, 114.0, 110.2.
Anal. Calcd for C31H27N3O2 (473.58): C, 78.62; H, 5.75. Found: C,
78.94; H, 5.61.
Anal. Calcd for C20H14N4O (326.36): C, 73.61; H, 4.32; N, 17.17.
Found: C, 73.54; H, 4.08; N, 16.96.
(E)-4-(Benzotriazol-1-yl)-5-ethoxy-1-(4-methylphenyl)-3,5-
diphenylpent-4-en-1-one (8b)
Yield: 1.59 g (65%); mp 136–138 °C.
(E)-2-Benzotriazol-1-yl-4-methyl-1-phenylpent-2-en-1-one (5e)
Yield: 0.59 g (67%); mp 110–112 °C.
1H NMR: d = 8.01 (d, J = 8.5 Hz, 1 H), 7.70 (d, J = 7.3 Hz, 2 H),
7.50–7.19 (m, 6 H), 6.83 (d, J = 10.5 Hz, 1 H), 2.41–2.31 (m, 1 H),
1.03 (d, J = 6.7 Hz, 6 H).
13C NMR: d = 190.4, 154.3, 145.3, 136.5, 133.9, 132.8, 132.0,
129.1, 128.5, 128.1, 124.0, 120.0, 109.7, 28.4, 22.1.
1H NMR: d = 8.08 (d, J = 8.2 Hz, 1 H), 7.78 (d, J = 7.2 Hz, 2 H),
7.62–7.30 (m, 11 H), 7.29 (d, J = 7.7 Hz, 2 H), 7.03 (d, J = 8.3 Hz,
2 H), 4.79 (t, J = 7.3 Hz, 1 H), 3.89 (q, J = 6.9 Hz, 2 H), 3.43 (dd,
3
2JAB = 7.2 Hz, J = 2.8 Hz, 1 H, A part of AB system), 3.43 (dd,
2JAB = 6.8 Hz, 3J = 2.3 Hz, 1 H, B part of AB system), 2.44 (s, 3 H),
0.86 (t, J = 6.9 Hz, 3 H).
13C NMR: d = 198.1, 156.2, 145.0, 140.8, 136.5, 135.0, 133.8,
132.1, 130.1, 129.9, 128.8, 128.2, 128.0, 127.6, 126.9, 126.7, 124.0,
123.6, 119.8, 118.6, 110.4, 66.2, 42.2, 41.9, 24.0, 15.1.
Anal. Calcd for C18H17N3O (291.36): C, 74.21; H, 5.88. Found: C,
73.93; H, 5.74.
(E)-2-Benzotriazol-1-yl-1-phenylpent-2-en-1-one (5f)
Yield: 0.61 g (73%); colorless microcrystals; mp 105–107 °C.
1H NMR: d = 8.02 (d, J = 8.5 Hz, 1 H), 7.67–7.21 (m, 8 H), 6.73 (t,
J = 7.9 Hz, 1 H), 2.13–1.99 (m, 2 H), 0.96 (t, J = 7.0 Hz, 3 H).
13C NMR: d = 191.2, 154.1, 144.8, 136.1, 133.5, 132.4, 131.3,
129.6, 129.0, 128.2, 123.6, 119.7, 110.1, 24.8, 17.3.
Anal. Calcd for C32H29N3O2 (487.61): C, 78.83; H, 5.99; N, 8.62.
Found: C, 78.46; H, 5.95; N, 8.85.
Substituted a,b-Unsaturated Ketones 5a–f; General Procedure
A mixture of compound 4 (3 mmol) and Br2 (0.3 mL, 6 mmol) in
CH2Cl2 (15 mL) was stirred for 30 min at 0 °C. The resultant mix-
ture was allowed to attain r.t. and stirred for an additional 3 h. Then
the solvent was evaporated in vacuo. The residue was subjected to
column chromatography on silica gel, and eluted with a mixture of
EtOAc–hexanes (1:10, then 1: 5) to give the desired product 5.
Anal. Calcd for C17H15N3O (277.33): C, 73.63; H, 5.45; N, 15.15.
Found: C, 73.42; H, 5.68; N, 15.02.
3-Substituted 1-(5-Phenylpyrazol-4-yl)benzotriazoles 9; Gener-
al Procedure
(E)-2-Benzotriazol-1-yl-3-(4-methylphenyl)-1-phenylprope-
none (5a)
Yield: 0.77 g (76%); mp 158–160 °C.
1H NMR: d = 8.10 (d, J = 8.5 Hz, 1 H), 7.83–7.18 (m, 13 H), 2.37
(s, 3 H), 2.17 (s, 3 H).
13C NMR: d = 189.9, 154.3, 146.0, 145.6, 133.8, 132.0, 131.5,
129.7, 128.9, 128.3, 127.9 127.6, 124.1, 119.9, 118.5, 111.7, 109.6,
21.0.
To a solution of b-keto vinyl ethers 7 (3 mmol) in EtOH (20 mL)
was added hydrazine hydrate or phenyl hydrazine (3.6 mmol). After
refluxing the mixture until the complete conversion of the starting
material (TLC control), it was concentrated under vacuum. The ob-
tained residue was purified by column chromatography on silica gel
(hexanes–EtOAc) to give 9a–d as pure products.
1-(3,5-Diphenyl-1H-pyrazol-4-yl)-1H-benzotriazole (9a)
Yield: 0.78 g (77%); mp 154–156 °C.
1H NMR: d = 12.33 (br s, 1 H), 7.99 (d, J = 8.2 Hz, 1 H), 7.75 (d,
J = 8.2 Hz, 1 H), 7.57–7.18 (m, 12 H).
Anal. Calcd for C22H17N3O (339.40): C, 77.86; H, 5.05; N, 12.38.
Found: C, 78.08; H, 5.13; N, 12.47.
13C NMR: d = 155.4, 149.3, 146.0, 140.2, 133.4, 132.7, 130.3,
(E)-2-Benzotriazol-1-yl-3-(4-methoxyphenyl)-1-phenylprope-
none (5b)
Yield: 0.76 g (71%); mp 175–177 °C.
1H NMR: d = 8.11–8.06 (m, 3 H), 7.55–7.12 (m, 9 H), 7.03 (d,
J = 8.8 Hz, 2 H), 3.93 (s, 3 H).
130.1, 129.2, 128.4 (2 C), 128.0, 127.5, 123.9, 123.2, 119.8, 109.8.
Anal. Calcd for C21H15N5 (337.39): C, 74.76; H, 4.48. Found: C,
74.66; H, 4.57.
13C NMR: d = 190.3, 156.1, 145.9, 133.8, 132.5, 131.7, 130.6,
129.7, 128.6, 128.3, 127.9, 127.0, 124.1, 120.6, 119.4, 114.2, 110.1,
55.0.
1-[3-(4-Methylphenyl)-5-phenyl-1H-pyrazol-4-yl]-1H-benzotri-
azole (9b)
Yield: 0.89 g (84%); mp 147–149 °C.
1H NMR: d = 11.98 (br s, 1 H), 8.05 (d, J = 8.2 Hz, 1 H), 7.87 (d,
J = 8.2 Hz, 1 H), 7.47–7.33 (m, 5 H), 7.29 (d, J = 7.5 Hz, 2 H), 7.18
(d, J = 8.2 Hz, 2 H), 7.08 (d, J = 8.0 Hz, 2 H), 2.27 (s, 3 H).
Anal. Calcd for C22H17N3O2 (355.40): C, 74.35; H, 4.82. Found: C,
74.02; H, 4.73.
13C NMR: d = 162.0, 156.6, 155.5, 146.3, 140.1, 133.3, 131.1,
129.9, 129.1, 128.5, 128.0, 127.6, 126.7, 124.2, 123.6, 119.8, 110.5,
21.2.
(E)-2-Benzotriazol-1-yl-3-(4-chlorophenyl)-1-phenylprope-
none (5c)
Yield: 0.81 g (75%); mp 189–191 °C.
1H NMR: d = 8.11 (dd, J = 2.1, 7.3 Hz, 1 H), 7.80–7.18 (m, 9 H),
7.13 (d, J = 7.1 Hz, 2 H), 6.77 (d, J = 7.0 Hz, 2 H).
Anal. Calcd for C22H17N5 (351.41): C, 75.19; H, 4.88; N, 19.93.
Found: C, 74.98; H, 4.52; N, 19.76.
13C NMR: d = 190.7, 145.6, 140.1, 137.2, 136.3, 132.9 (2C), 131.5,
1-(1,3,5-Triphenyl-1H-pyrazol-4-yl)-1H-benzotriazole (9c)
Yield: 1.02 g (82%); mp 168–170 °C.
131.2, 129.6, 129.1, 129.0, 128.6, 128.5, 124.4, 120.1, 109.8.
Anal. Calcd for C21H14ClN3O (359.82): C, 70.10; H, 3.92; N, 11.68.
Found: C, 70.43; H, 4.22; N, 11.41.
Synthesis 2005, No. 2, 245–249 © Thieme Stuttgart · New York